News 4basebio PLC

Equities

Delayed London S.E. Other stock markets 12:48:14 29/04/2024 BST			5-day change	1st Jan Change
1,096 ^GBX	+2.43%		+4.88%	+61.18%

04-10	4basebio to supply synthetic DNA for mRNA vaccine program	AN
04-10	4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	CI

4basebio to supply synthetic DNA for mRNA vaccine program	04-10	AN
4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program	04-10	PR
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	04-10	CI
4basebio updates markets on "key milestone" with client	03-21	AN
4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine	03-21	PR
Alpha Real Trust says in "robust" financial shape	03-01	AN
4basebio wins DNA supply contract to support RNA therapies	03-01	AN
4basebio Wins Synthetic DNA Supply Tender from CPI	03-01	MT
4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence	03-01	PR
4basebio Plc - Holding(s) in Company	02-06	PR
4basebio Plc - Holding(s) in Company	02-06	PR
4basebio Plc - Holding(s) in Company	02-06	PR
4basebio Plc - Holding(s) in Company	02-06	PR
4basebio Plc - Exercise of Options	02-06	PR
4basebio Plc - Holding(s) in Company	02-05	PR
4basebio Plc - Holding(s) in Company	02-05	PR
4basebio Plc - Holding(s) in Company	02-05	PR
4basebio Plc - Directors' Dealings	02-05	PR
4basebio Plc - Long-Term Incentive Plan and Exercise of Options	02-02	PR
4basebio interim loss widens as research costs increase	21/09/23	AN

No results for this search